Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IP6K1 | Q92551 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 4/20 | 0.53 |
| ▸ | RAB9A | P51151 | 4/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | KIF11 | P52732 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.42 |
| ▸ | PDE2A | O00408 | 1/20 | 0.41 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.41 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.40 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.40 |
| ▸ | NTRK3 | Q16288 | 2/20 | 0.40 |
| ▸ | NTRK2 | Q16620 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3276501 | 1.00 | IP6K1 (0.56) | IP6K1NPC1RAB9AKMT2AMEN1 | |
| SCHEMBL3270430 | 0.81 | RAB9A (0.55) | IP6K1NPC1RAB9AKMT2AMEN1 | |
| SCHEMBL3270434 | 0.81 | RAB9A (0.55) | IP6K1NPC1RAB9AKMT2AMEN1 | |
| SCHEMBL11250285 | 0.78 | KIF11 (0.56) | IP6K1NPC1RAB9AKMT2AMEN1 | |
| SCHEMBL11250289 | 0.78 | KIF11 (0.56) | IP6K1NPC1RAB9AKMT2AMEN1 | |
| SCHEMBL29419010 | 0.78 | KMT2A (0.80) | IP6K1NPC1RAB9AKMT2AMEN1 | |
| SCHEMBL28595722 | 0.78 | KMT2A (0.80) | IP6K1NPC1RAB9AKMT2AMEN1 | |
| SCHEMBL709077 | 0.76 | CYP2A6 (0.50) | IP6K1NPC1RAB9AKMT2AMEN1 | |
| SCHEMBL709076 | 0.76 | CYP2A6 (0.50) | IP6K1NPC1RAB9AKMT2AMEN1 | |
| SCHEMBL6478283 | 0.76 | HDAC8 (0.44) | IP6K1NPC1RAB9AKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7691624-B2 | Cancer cell detecting devices | ACADEMIA SINICA (TW) | 2010-04-06 | — | — | US | disclosed |
| US-7691624-B2 | Cancer cell detecting devices | ACADEMIA SINICA (TW) | 2010-04-06 | — | — | US | disclosed |
| US-7691624-B2 | Cancer cell detecting devices | ACADEMIA SINICA (TW) | 2010-04-06 | — | — | US | disclosed |
| US-20070098233-A1 | Cancer cell detecting devices | ACADEMIA SINICA | 2007-05-03 | — | — | US | disclosed |
| US-20070098233-A1 | Cancer cell detecting devices | ACADEMIA SINICA | 2007-05-03 | — | — | US | disclosed |
| US-20070098233-A1 | Cancer cell detecting devices | ACADEMIA SINICA | 2007-05-03 | — | — | US | disclosed |
| US-6979738-B2 | for human telomeres/telomerases; drug screening | ACADEMIA SINICA (TW) | 2005-12-27 | — | — | US | disclosed |
| US-20050249669-A1 | Quadruplex stabilizer | ACADEMIA SINICA | 2005-11-10 | — | — | US | disclosed |
| US-20050090671-A1 | Quadruplex stabilizer | ACADEMIA SINICA (TW) | 2005-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050090671-A1 | Quadruplex stabilizer | HNRNPA3, HNRNPR, HNRNPC | IP6K1 2919/4885NPC1 2484/4885RAB9A 2511/4885 |
| US-20050249669-A1 | Quadruplex stabilizer | HNRNPA3, HNRNPR, ANXA3 | IP6K1 3300/4885NPC1 2730/4885RAB9A 2134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.